0001144204-16-125866.txt : 20160928
0001144204-16-125866.hdr.sgml : 20160928
20160928210019
ACCESSION NUMBER: 0001144204-16-125866
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160926
FILED AS OF DATE: 20160928
DATE AS OF CHANGE: 20160928
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001270073
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223868459
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 450 W. 15TH STREET
STREET 2: SUITE 505
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: 646-747-1000
MAIL ADDRESS:
STREET 1: 450 W. 15TH STREET
STREET 2: SUITE 505
CITY: New York
STATE: NY
ZIP: 10011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shapiro David
CENTRAL INDEX KEY: 0001559570
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35668
FILM NUMBER: 161908182
MAIL ADDRESS:
STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC.
STREET 2: 18 DESBROSSES ST.
CITY: NEW YORK
STATE: NY
ZIP: 10013
4
1
v449570_4.xml
OWNERSHIP DOCUMENT
X0306
4
2016-09-26
0
0001270073
INTERCEPT PHARMACEUTICALS INC
ICPT
0001559570
Shapiro David
C/O INTERCEPT PHARMACEUTICALS, INC.
450 W. 15TH STREET, SUITE 505
NEW YORK
NY
10011
0
1
0
0
CMO and EVP - Development
Common Stock
2016-09-26
4
S
0
2659
164.7601
D
45732
D
Common Stock
2016-09-26
4
S
0
886
166.03
D
44846
D
The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person.
This transaction was executed in multiple trades at prices ranging from $164.5201 to $165.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Bryan Yoon, as attorney-in-fact
2016-09-28